Stay updated on Galunisertib with Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Galunisertib with Nivolumab in Solid Tumors Clinical Trial page.

Latest updates to the Galunisertib with Nivolumab in Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe revision tag on the page updated from v3.5.3 to v3.5.4, signaling a minor backend update to the page. The visible content and user-facing information remain unchanged.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page’s site revision label updated from **v3.5.2** to **v3.5.3** at the bottom of the ClinicalTrials.gov study page.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0; this appears to be a backend/maintenance update with no visible changes to study details or page content.SummaryDifference0.0%

- Check88 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3. No substantive study information appears to be altered.SummaryDifference0.0%

- Check110 days agoChange DetectedA revision tag was updated from v3.4.1 to v3.4.2, indicating a backend/content-management update with no evident impact on study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Galunisertib with Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galunisertib with Nivolumab in Solid Tumors Clinical Trial page.